Cassava Sciences Inc (NASDAQ: SAVA): Stock That Needs Special Handling

Currently, there are 42.24M common shares owned by the public and among those 41.77M shares have been available to trade.

The company’s stock has a 5-day price change of -88.07% and -86.62% over the past three months. SAVA shares are trading -82.94% year to date (YTD), with the 12-month market performance down to -81.30% lower. It has a 12-month low price of $3.65 and touched a high of $42.20 over the same period. SAVA has an average intraday trading volume of 4.26 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -82.67%, -84.92%, and -82.97% respectively.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Institutional ownership of Cassava Sciences Inc (NASDAQ: SAVA) shares accounts for 29.65% of the company’s 42.24M shares outstanding.

It has a market capitalization of $178.24M and a beta (3y monthly) value of -0.82. The earnings-per-share (ttm) stands at -$1.37. Price movements for the stock have been influenced by the stock’s volatility, which stands at 18.43% over the week and 11.68% over the month.

Earnings per share for the fiscal year are expected to increase by 62.79%, and 49.61% over the next financial year.

H.C. Wainwright coverage for the Cassava Sciences Inc (SAVA) stock in a research note released on October 08, 2024 offered a Buy rating with a price target of $116. H.C. Wainwright was of a view on July 01, 2024 that the stock is Neutral, while B. Riley Securities gave the stock Neutral rating on November 16, 2022, issuing a price target of $44. Cantor Fitzgerald on their part issued Neutral rating on July 15, 2021.

Most Popular

Related Posts